Table 2.
Survival rates in TUH HNSCC patient cohort compared with Eurocare-5 data for Northern Europe
| Oral cavity | Larynx | Oropharynx | Hypopharynx | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HNSCC | Eurocare | HNSCC | Eurocare | HNSCC | Eurocare | HNSCC | Eurocare | HNSCC | Eurocare | |
| OAS 5-years | 56% | – | 48% | – | 70% | – | 30% | – | 53% | – |
| DSS 5-years | 71% | – | 69% | – | 65% | – | 40% | – | 68% | – |
| ICSS 5-year observed survival rate | 58% | 43% | 50% | 52% | 57% | 41% | 36% | 17% | 53% | 41% |
| ICSS 5-year relative survival rate | – | 50% | – | 62% | – | 46% | – | 19% | – | 46% |
Eurocare-5 data accessed at https://w3.iss.it/site/EU5Results/